Table 2.
BALF cell concentration and differential cell count | ||
---|---|---|
Before treatment | After treatment | |
Total number of cells | 17·3 (7·6–44·7) | 17·6 (10·5–39·5) |
Cellconcentration (×106/l) | 136·6 (83·1–262·8) | 147·8 (88·9–213·8) |
Macrophages (%) | 76·6 (58·0–93·6) | 79·4 (61·8–95·0) |
Lymphocytes (%) | 20·0 (4·2–40·0) | 15·6 (2·6–37·6) |
Neutrophils (%) | 2·2 (1·2–9·6) | 2·4 (0·2–13·2) |
Eosinophils (%) | 0·4 (0·0–2·2) | 0·0 (0·0–3·4) |
Basophils (%) | 0·0 (0·0–0·2) | 0·0 (0·0–0·4) |
Mastcells | 4·0 (0·0–36·0) | 9·0 (0·0–39·0) |
CD4/CD8 ratio | 3·9 (2·6–8·5) | 4·0 (3·0–11·6) |
(a) Data are shown as median (min–max). (b) Mast cells are shown as the number of cells observed in 10 visual fields (×16 magnification).